ORIC — Oric Pharmaceuticals Inc. stock price and chart

Share this page

ORIC

$12.35-3.29%

as of close, Oct 16, 2026

☾ AH $12.35 -3.29%

Oric Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.03%Nasdaq Composite 0.003%US Stock Market 0.001%Russell 3000 0.0010%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Apr 29, 2020

VolumeEEEE

20202021202320252026

5.010.015.020.025.030.035.0020.0M40.0M$12.35

2026-10-16

Price$12.35

MA20$12.43

MA50$11.08

Vol945.6K

What would $1,000 invested in ORIC be worth today? →

ORIC returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $12.35
YTD price return: +50.98%
YTD total return: +50.98%
Next earnings: Nov 12, 2026
Market cap: 1.3B2020-06 1B2026-10 1.3B+26.7% over the window
Enterprise value: 1.3B
Shares outstanding: 103.7M2019-12 2M2026-06 103.7M+5123.8% over the window
52W low: $7.23
52W high: $14.68
From 52W high: -15.87%
From 52W low: +70.82%
52W range: 69%

Volume

Rel volume: 0.63×
30D volume: 1.5M
30D $ vol: 19M

Fundamentals

EPS (ttm): -$1.352021-06 -$2.492026-06 -$1.35-45.7% over the window
FCF (ttm): -112.3M2018-12 -21.2M2026-06 -112.3M+429.3% over the window
FCF/share: -$1.082019-12 -$12.252026-06 -$1.08-91.2% over the window
Book value/share: $3.682019-06 -$38.272026-06 $3.68-109.6% over the window
ROE: -36.81%2020-06 -17.8%2026-06 -36.8%+106.5% over the window
ROA: -34.68%2019-12 -28.6%2026-06 -34.7%+21.4% over the window
Current ratio: 13.192019-12 16.812026-06 13.19-21.6% over the window

Growth (CAGR, ttm) · 10Y

Shares: +6.73%2025-06-30 → 2026-06-3097.1M → 103.7M (+6.7% total)+23.87%2023-06-30 → 2026-06-3054.5M → 103.7M (+90.1% total)+21.40%2021-06-30 → 2026-06-3039.3M → 103.7M (+163.6% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share: +10.27%2025-06-30 → 2026-06-30$3.34 → $3.68 (+10.3% total)-9.29%2023-06-30 → 2026-06-30$4.93 → $3.68 (-25.4% total)-10.96%2021-06-30 → 2026-06-30$6.57 → $3.68 (-44.0% total)n/a
Price: -7.15%2025-10-16 → 2026-10-16$13.30 → $12.35 (-7.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+30.23%2023-10-16 → 2026-10-16$5.59 → $12.35 (+120.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-5.32%2021-10-15 → 2026-10-16$16.23 → $12.35 (-23.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: -7.15%2025-10-16 → 2026-10-16$13.30 → $12.35 (-7.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+30.23%2023-10-16 → 2026-10-16$5.59 → $12.35 (+120.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-5.32%2021-10-15 → 2026-10-16$16.23 → $12.35 (-23.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -9.1×2020-06 -29.042026-10 -9.12-68.6% over the window
Fwd P/E: -7.2×
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.4×2020-06 5.182026-10 3.36-35.1% over the window
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -8.77%2020-03 -2.7%2026-06 -10.0%+274.9% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 103.7M ÷ 97.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -6.73%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-6.73%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($985.8M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -6.73%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-171.3M) ÷ today's market cap ($1.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -13.38%2020-03 0.0%2026-06 -15.3%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-171.3M + TTM dividends $0) ÷ today's market cap ($1.3B). Same caveat as the cash buyback yield.: -13.38%2020-03 0.0%2026-06 -15.3%

Vs own 10Y history

P/B: 82nd

Bar = where today’s multiple sits in ORIC’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-3.29%

+3.00%

-1.52%

+15.10%

YTD

+50.98%

-7.14%

-23.91%

Financial statements

Open full ORIC financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

ORIC — Oric Pharmaceuticals Inc. price, chart and key statistics